Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer models

96

Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer models

Tags:

Previous Article

Increased cholesterol synthesis drives neurotoxicity in multiple sclerosis

Animal model for antitumor immunity in lung cancer

Related Posts

Membrane receptors cluster phosphatidylserine to activate LC3-associated phagocytosis

Membrane receptors cluster phosphatidylserine to activa...

66

Integrated computational approaches for advancing antimicrobial peptide development

Integrated computational approaches for advancing antim...

109

Oligodendrocyte mechanotransduction channel TMEM63A regulates myelin sheath geometry

Oligodendrocyte mechanotransduction channel TMEM63A reg...

60